Which of the following agents is used for the treatment of Thrombocytopenia secondary to myelosupressive cancer chemotherapy: (A) Filgrastim, (B) Sargramostim, (C) Oprelvekin, (D) Erythropoetin
Answer is C. Ans is 'c' i.e. Oprelvekin Oprelvekin (Recombinant IL-11) is used in chemotherapy induced thrombocytopenia.